ALPHATEC HOLDINGS, INC. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-04-28: Measure Total revenue.
- 2023-04-28: Measure Adjusted EBITDA.
- 2023-04-28: Measure Adjusted EBITDA margin..
- 2024-04-26: Measure Total revenue.
| Proxy filed | Measure |
|---|---|
| 2023-04-28 | Total revenue |
| 2023-04-28 | Adjusted EBITDA |
| 2023-04-28 | Adjusted EBITDA margin. |
| 2024-04-26 | Total revenue |
| 2024-04-26 | Adjusted EBITDA |
| 2024-04-26 | Adjusted EBITDA margin. |
| 2025-04-25 | Total revenue |
| 2025-04-25 | Adjusted EBITDA |
| 2025-04-25 | Adjusted EBITDA margin. |
| 2026-04-29 | Total revenue |
| 2026-04-29 | Adjusted EBITDA |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |